bpc 157 fda compounding category BPC-157 Legal Status: Regulations and New FDA peptide advisers could
New FDA peptide advisers could benefit from their own rulings STAT HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT The FDA cracked down on BPC 157 and now the biohackers are losing their minds
Pay in 4 interest-free payments of $6.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



